NEW YORK (GenomeWeb) – A new genomic and transcriptomic analysis of rare, soft tissue tumors that develop in infants has detected recurrent EGFR and BRAF rearrangements that may render them vulnerable to targeted treatment.
NEW YORK (GenomeWeb) – A new genomic and transcriptomic analysis of rare, soft tissue tumors that develop in infants has detected recurrent EGFR and BRAF rearrangements that may render them vulnerable to targeted treatment.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.